Provided by Tiger Trade Technology Pte. Ltd.

Sangamo Therapeutics Inc

0.1350
+0.015813.26%
Post-market: 0.1314-0.0036-2.67%19:59 EDT
Volume:17.42M
Turnover:2.18M
Market Cap:55.89M
PE:-0.31
High:0.1372
Open:0.1180
Low:0.1180
Close:0.1192
52wk High:0.7750
52wk Low:0.1155
Shares:414.00M
Float Shares:364.00M
Volume Ratio:0.73
T/O Rate:4.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4400
EPS(LYR):-0.4400
ROE:-2891.84%
ROA:-83.66%
PB:-3.92
PE(LYR):-0.31

Loading ...

Sangamo presents neurology epigenetic regulation data at ASGCT annual meeting

Reuters
·
Apr 30

BRIEF-Sangamo Therapeutics To Transition Common Stock To Otcqb Venture Market On May 5, 2026

Reuters
·
Apr 29

Sangamo shares set to move to OTCQB as Nasdaq delists stock May 5

Reuters
·
Apr 29

Sangamo Therapeutics Inc - to Transition Common Stock to Otcqb Venture Market on May 5, 2026

THOMSON REUTERS
·
Apr 29

H.C. Wainwright Reaffirms Their Buy Rating on Sangamo Therapeutics (SGMO)

TIPRANKS
·
Apr 29

Sangamo Head of Research Gregory Davis sells 69,827 shares for $17,694

Reuters
·
Apr 24

Sangamo SVP Nathalie Dubois-Stringfellow sells 345,942 shares for $89,186

Reuters
·
Apr 24

Analysts Have Conflicting Sentiments on These Healthcare Companies: Terns Pharmaceuticals (TERN), Sangamo Therapeutics (SGMO) and Galectin Therapeutics (GALT)

TIPRANKS
·
Mar 31

Sangamo Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 31

Sangamo reports Q4 EPS (11c), consensus (5c)

TIPRANKS
·
Mar 31

Sangamo publishes corporate presentation highlighting neurology genomic medicines pipeline, Fabry BLA progress

Reuters
·
Mar 31

Sangamo Q4 revenue misses analyst expectations

Reuters
·
Mar 31

Sangamo FY25 net loss widens to $123 million; revenue drops to $40 million

Reuters
·
Mar 31

BRIEF-Sangamo Therapeutics Q4 EPS USD -0.11

Reuters
·
Mar 31

Sangamo Therapeutics Q4 Revenue USD 14.228 Million

THOMSON REUTERS
·
Mar 31

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

THOMSON REUTERS
·
Mar 31

Sangamo options imply 27.2% move in share price post-earnings

TIPRANKS
·
Mar 31

Options Volatility and Implied Earnings Moves Today, March 30, 2026

TIPRANKS
·
Mar 30

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 30

Sangamo Therapeutics Inc expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
Mar 28